Dr.Clokie is a professional surgeon who also doubles as a scientist and a successful entrepreneur. Besides, he acts as the Chief Executive Officer of Biologics Inc., a company dealing with medicine and focuses on improvised solutions for reconstruction of musculoskeletal. For many years, he was part of an academic dentistry and clinical applications.
In 1985, Cameron Clokie obtained his Doctor of Dental Surgeon (DDS) followed by a bone regeneration and development Ph.D. from McGill University. He was selected to be Head of Oral and Maxillofacial Surgery. Read more: Dr. Cameron Clokie Gives His Quick Tips for Tooth Care While Traveling
Cameron also was a Professor working at the University of Toronto and also at Oral and Maxillofacial Surgery until when he retired from academics in 2017. Besides, he served on scientific advisory boards for various companies.
Dr. Clokie work was published in several papers together with many presentations. He obtained both national and international recognition for the great developments in bone reconstruction and regenerative medicine. The holder of twenty-five US and worldwide current and pending patents among those of bone curing, Cameron Clokie has developed a formidable partnership with various businesses and has passed his unique knowledge and skill into financially profitable enterprises.
During the late 1990s, Dr. Cameron Clokie carried out BMP tests in his quest for reconstructive jaw surgery. In the process, he discovered that he required a lot of bone to obtain the expected result. He persisted with the tests which came to fruition in 1999 when he repaired the first jawbone in the world with BMP.
It was a very cumbersome procedure that needed to grind bones of forty cadavers to obtain three milligrams of protein. Consequently, Dr. Clokie had to venture into a viable measure. He identified a biotech firm that generates BMP in cells of Chinese hamsters. That source enabled him to perform the procedure severally with ease.
Dr. Clokie is now planning to produce BMP by putting in a human gene which generates it into goat embryos. It is a way that will promote goats to produce the protein in their milk in bulk.
The focal point of all these endeavors is to create bioimplants that will finally substitute the requirement for autogenous bone grafts.